Literature DB >> 10085018

Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.

S Lukomski1, C A Montgomery, J Rurangirwa, R S Geske, J P Barrish, G J Adams, J M Musser.   

Abstract

The role of an extracellular cysteine protease encoded by the speB gene in group A Streptococcus (GAS) skin infection was studied with a mouse model. Mice were injected subcutaneously with a wild-type GAS serotype M3 strain or a cysteine protease-inactivated isogenic derivative grown to stationary phase. The mortality rate of mice injected with the M3 speB mutant strain was significantly decreased (P < 0.0008) compared to that of animals injected with the wild-type parental organism. The abscesses formed in animals infected with the cysteine protease mutant strain were significantly smaller (P < 0.0001) than those caused by the wild-type organism and slowly regressed over 3 to 4 weeks. In striking contrast, infection with the wild-type GAS isolate generated necrotic lesions, and in some animals the GAS disseminated widely from the injection site and produced extensive cutaneous damage. All of these animals developed bacteremia and died. GAS dissemination was accompanied by severe tissue and blood vessel necrosis. Cysteine protease expression in the infected tissue was identified by immunogold electron microscopy. These data demonstrate that cysteine protease expression contributes to soft tissue pathology, including necrosis, and is required for efficient systemic dissemination of the organism from the initial site of skin inoculation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085018      PMCID: PMC96528          DOI: 10.1128/IAI.67.4.1779-1788.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  Control of growth and differentiation of vascular cells by extracellular matrix proteins.

Authors:  D J Carey
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

2.  Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion.

Authors:  M S Chaussee; E R Phillips; J J Ferretti
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Spontaneous gangrenous myositis induced by Streptococcus pyogenes: case report and review of the literature.

Authors:  E L Yoder; J Mendez; R Khatib
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

Review 4.  Fibronectin: an enhancer of phagocyte function.

Authors:  R A Proctor
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

5.  Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection.

Authors:  M D Boyle; R Raeder; A Flosdorff; A Podbielski
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

6.  Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia.

Authors:  L K Husmann; D L Yung; S K Hollingshead; J R Scott
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

7.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.

Authors:  V Kapur; M W Majesky; L L Li; R A Black; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Genetic inactivation of the extracellular cysteine protease enhances in vitro internalization of group A streptococci by human epithelial and endothelial cells.

Authors:  E H Burns; S Lukomski; J Rurangirwa; A Podbielski; J M Musser
Journal:  Microb Pathog       Date:  1998-06       Impact factor: 3.738

9.  Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection.

Authors:  C F Kuo; J J Wu; K Y Lin; P J Tsai; S C Lee; Y T Jin; H Y Lei; Y S Lin
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  64 in total

Review 1.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Role of RopB in growth phase expression of the SpeB cysteine protease of Streptococcus pyogenes.

Authors:  Melody N Neely; William R Lyon; Donna L Runft; Michael Caparon
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

3.  An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes.

Authors:  Samuel A Shelburne; Randall J Olsen; Nishanth Makthal; Nicholas G Brown; Pranoti Sahasrabhojane; Ebru M Watkins; Timothy Palzkill; James M Musser; Muthiah Kumaraswami
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

4.  Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.

Authors:  S Lukomski; N P Hoe; I Abdi; J Rurangirwa; P Kordari; M Liu; S J Dou; G G Adams; J M Musser
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Authors:  R Raeder; E Harokopakis; S Hollingshead; M D Boyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Streptococcal pyrogenic exotoxin B-induced apoptosis in a549 cells is mediated by a receptor- and mitochondrion-dependent pathway.

Authors:  Wan-Hua Tsai; Chia-Wen Chang; Woei-Jer Chuang; Yee-Shin Lin; Jiunn-Jong Wu; Ching-Chuan Liu; Wen-Tsan Chang; Ming T Lin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.

Authors:  Anthony R Flores; Brittany E Jewell; Randall J Olsen; Samuel A Shelburne; Nahuel Fittipaldi; Stephen B Beres; James M Musser
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

8.  Rgg protein structure-function and inhibition by cyclic peptide compounds.

Authors:  Vijay Parashar; Chaitanya Aggarwal; Michael J Federle; Matthew B Neiditch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

9.  Relevance of peptide uptake systems to the physiology and virulence of Streptococcus agalactiae.

Authors:  Ulrike Samen; Birgit Gottschalk; Bernhard J Eikmanns; Dieter J Reinscheid
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

10.  SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.

Authors:  Arne Egesten; Anders I Olin; Helena M Linge; Manisha Yadav; Matthias Mörgelin; Anna Karlsson; Mattias Collin
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.